KBC Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,303
| Closed | -$41K | – | 1762 |
|
|
2025
Q1 | $41K | Hold |
12,303
| – | – | ﹤0.01% | 1822 |
|
|
2024
Q4 | $91K | Buy |
12,303
+6,321
| +106% | +$46.8K | ﹤0.01% | 1621 |
|
|
2024
Q3 | $56K | Hold |
5,982
| – | – | ﹤0.01% | 1656 |
|
|
2024
Q2 | $48K | Buy |
5,982
+1,607
| +37% | +$12.9K | ﹤0.01% | 1646 |
|
|
2024
Q1 | $65K | Sell |
4,375
-198
| -4% | -$2.94K | ﹤0.01% | 1381 |
|
|
2023
Q4 | $37K | Hold |
4,573
| – | – | ﹤0.01% | 1708 |
|
|
2023
Q3 | $21K | Buy |
+4,573
| New | +$21K | ﹤0.01% | 1876 |
|
|
2020
Q4 | – | Sell |
-1,200
| Closed | -$40K | – | 1276 |
|
|
2020
Q3 | $40K | Hold |
1,200
| – | – | ﹤0.01% | 1214 |
|
|
2020
Q2 | $32K | Buy |
1,200
+600
| +100% | +$16K | ﹤0.01% | 1255 |
|
|
2020
Q1 | $18K | Hold |
600
| – | – | ﹤0.01% | 1257 |
|
|
2019
Q4 | $17K | Buy |
600
+380
| +173% | +$10.8K | ﹤0.01% | 1460 |
|
|
2019
Q3 | $4K | Hold |
220
| – | – | ﹤0.01% | 1469 |
|
|
2019
Q2 | $5K | Buy |
+220
| New | +$5K | ﹤0.01% | 1449 |
|